financetom
Business
financetom
/
Business
/
Core Scientific Reports Lower Bitcoin Sales, Production in August
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Core Scientific Reports Lower Bitcoin Sales, Production in August
Sep 6, 2024 12:59 PM

09:08 AM EDT, 09/05/2024 (MT Newswires) -- Core Scientific ( CORZ ) said Thursday it sold 375 bitcoins in August for proceeds of about $22.5 million, down from 401 bitcoins sold for about $25.2 million in July.

The company said it earned 358 bitcoins from its owned fleet of miners in August, down from 411 in the previous month.

Shares of Core Scientific ( CORZ ) rose 2.8% in recent premarket activity.

Price: 10.15, Change: +0.28, Percent Change: +2.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Edible Garden Seeks to Raise $5 Million in Public Offering to Comply with Nasdaq's Minimum Equity Requirement
Edible Garden Seeks to Raise $5 Million in Public Offering to Comply with Nasdaq's Minimum Equity Requirement
Sep 6, 2024
07:49 AM EDT, 09/06/2024 (MT Newswires) -- Edible Garden ( EDBL ) said Friday it plans to offer up to about 4.7 million units to the public for $1.07 apiece to raise about $5 million, in a bid to comply with the Nasdaq Capital Market's minimum shareholder's equity of $2.5 million. Each unit consists of one common share and a...
AvalonBay Communities Shares Fall Pre-Bell After 3.2-Million-Share Public Offering
AvalonBay Communities Shares Fall Pre-Bell After 3.2-Million-Share Public Offering
Sep 6, 2024
07:39 AM EDT, 09/06/2024 (MT Newswires) -- AvalonBay Communities ( AVB ) shares were down 2% in Friday's premarket activity after the company priced a public offering of 3.2 million shares of common stock as part of a forward sale agreement with expected total proceeds of about $710.4 million. Forward purchasers or their affiliates will borrow and sell to the...
GSK's Phase 3 Trial of Nucala to Treat COPD Meets Primary Endpoint; Shares Rise 1% Pre-Bell
GSK's Phase 3 Trial of Nucala to Treat COPD Meets Primary Endpoint; Shares Rise 1% Pre-Bell
Sep 6, 2024
07:48 AM EDT, 09/06/2024 (MT Newswires) -- GSK (GSK) said Friday that a phase 3 trial evaluating Nucala in adults with chronic obstructive pulmonary disease met its primary endpoint. The British pharmaceutical company said the study results showed a statistically significant and clinically meaningful reduction in the annualized rate of moderate to severe exacerbations compared to placebo. Shares of GSK...
Top Premarket Gainers
Top Premarket Gainers
Sep 6, 2024
07:47 AM EDT, 09/06/2024 (MT Newswires) -- Beneficient (BENF) shares soared 81% pre-bell Friday following a 1.3% loss in the previous session. Wheeler REIT (WHLR) shares surged 84% after saying that an appeals court affirmed the dismissal of a class action lawsuit filed against it. Argan (AGX) shares rose 19% on higher fiscal Q2 earnings and revenue. Faraday Future (FFIE)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved